Overview

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy.
Phase:
N/A
Details
Lead Sponsor:
Stanford University